# Axonics Women's Health (Axonics Women's Health Limited)

Private limited company registered in Hemel Hempstead, classed under “Manufacture of pharmaceutical preparations”.

- Company number: 03145216
- Status: Active
- Type: Private limited company
- Incorporated: 11 January 1996
- Registered office: Breakspear Park, Breakspear Way, Hemel Hempstead, Hertfordshire, HP2 4TZ
- Location: Hemel Hempstead, Hertfordshire
- Activity: Manufacture of pharmaceutical preparations

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Axonics Women's Health do?

Private limited company registered in Hemel Hempstead, classed under “Manufacture of pharmaceutical preparations”.

### How much turnover does Axonics Women's Health make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/axonics-womens-health-03145216

### Is Axonics Women's Health profitable?

Axonics Women's Health's profit isn't public: small companies may file without a profit and loss account.

### Who runs and owns Axonics Women's Health?

Its directors are Emily Marie Woodworth, Abogado Nominees Limited, Emily Marie Woodworth. Its owners are shown to subscribers.

### Where is Axonics Women's Health based?

Its registered office is Breakspear Park, Breakspear Way, Hemel Hempstead, Hertfordshire, HP2 4TZ, in Hemel Hempstead, Hertfordshire.

### When was Axonics Women's Health founded?

Axonics Women's Health Limited was incorporated on 11 January 1996.

### Is Axonics Women's Health still trading?

The register lists Axonics Women's Health Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-10-02: Full accounts made up to 31 December 2025
- 2026-03-17: Compulsory strike-off action has been discontinued
- 2026-03-16: Full accounts made up to 31 December 2024
- 2026-03-03: First Gazette notice for compulsory strike-off
- 2025-06-13: Register(s) moved to registered inspection location
- 2025-06-13: Register inspection address has been changed
- 2025-05-28: Full accounts made up to 31 December 2023
- 2024-11-20: Termination of appointment of Kari Keese as a director on 15 November 2024
- 2024-11-20: Appointment of Abogado Nominees Limited as a secretary on 15 November 2024
- 2024-11-20: Termination of appointment of Raymond Wayne Cohen as a director on 15 November 2024
- 2024-11-20: Appointment of Emily Marie Woodworth as a secretary on 15 November 2024
- 2024-11-20: Appointment of Emily Marie Woodworth as a director on 15 November 2024
- 2024-11-20: Termination of appointment of Gravitas Company Secretarial Services Limited as a secretary on 15 November 2024
- 2024-11-20: Change of details for Axonics Modulation Technologies, U.K. Limited as a person with significant control on 15 November 2024
- 2024-11-20: Registered office address changed from 5th Floor One New Change London EC4M 9AF United Kingdom to Breakspear Park Breakspear Way Hemel Hempstead Hertfordshire HP2 4TZ on 20 Nove…
- 2024-03-19: Full accounts made up to 31 December 2022
- 2023-10-11: Appointment of Kari Keese as a director on 2 October 2023
- 2023-10-11: Termination of appointment of Danny Lee Dearen as a director on 30 September 2023
- 2023-02-13: Full accounts made up to 31 December 2021
- 2022-07-13: Resolutions (and 7 more like it since 17 April 2014)
- 2022-07-12: Change of share class name or designation (and 2 more like it since 17 April 2014)
- 2022-07-12: Particulars of variation of rights attached to shares (and 1 more like it since 17 April 2014)
- 2022-01-10: Group of companies' accounts made up to 31 December 2020
- 2021-05-24: Appointment of Gravitas Company Secretarial Services Limited as a secretary on 6 May 2021
- 2021-03-09: Memorandum and Articles of Association (and 2 more like it since 17 April 2014)

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/axonics-womens-health-03145216
